IM Therapeutics launches with T1D candidate

Autoimmune company ImmunoMolecular Therapeutics LLC (Broomfield, Colo.) emerged from stealth mode with a small molecule candidate that aims to treat Type I diabetes by preventing the initiation of

Read the full 289 word article

How to gain access

Continue reading with a
two-week free trial.